Systems biology of Wnt signaling in glioma chemotherapy resistance: Integrating multi-omics mechanisms and emerging therapeutic vulnerabilities (Review). [PDF]
Zeng Q, Chen Z, Zhang R, Pan H.
europepmc +1 more source
Multi‐omics integration of the transcriptomic APA landscape and m6A modifications identifies key prognostic genes. Their biological functions and molecular mechanisms in promoting tumor progression are comprehensively validated through in vitro assays. ABSTRACT Alternative polyadenylation (APA) and N6‐methyladenosine (m6A) methylation are critical post‐
Zhuoyi Wu +6 more
wiley +1 more source
Oncogenic EGFR Signaling as a Central Regulator of Chemoresistance in Ovarian Cancer: A Mechanistic Review. [PDF]
Nagappan A +4 more
europepmc +1 more source
YBX1 Promotes Malignant Progression of HNSCC via Stabilizing NSUN2‐m5C Modified ATF4 mRNA
The diagram depicts the core axis and the key finding: “Targeting YBX1/NSUN2 abrogates HNSCC progression”. Within left‐sided HNSCC cells, NSUN2 mediates m5C methylation on the CDS of ATF4 mRNA; YBX1 then specifically recognizes and binds this modified site, augmenting ATF4 mRNA stability, which ultimately promotes cancer cell proliferation, migration ...
Yanwei Li +3 more
wiley +1 more source
Autophagy Modulation in Cancer Therapy: Navigating the Dual Roles to Overcome Chemoresistance. [PDF]
Mohiuddin M, Ahsan MAM.
europepmc +1 more source
DNA hypermethylation causally correlates with better treatment response of HPV(+) HNSCC, and its chemosensitivity might be enhanced by silencing of methylation target genes. Silencing of ROBO1 enhances, and its overexpression reduces, CDDP chemosensitivity, and epigenetic or ROBO1‐targeted interventions may improve therapeutic outcomes in resistant HPV(
Kenta Saeda +11 more
wiley +1 more source
Correction: Overcoming chemoresistance in esophageal cancer with synergistic strategies. [PDF]
Gao C +19 more
europepmc +1 more source
Patient-Derived Organoid and Single-Cell Multiomics Reveal Evolution Driven by CEACAM6/KRT19-Mediated Heterogeneity. [PDF]
Jing C +7 more
europepmc +1 more source
ALDH2 regulates oxaliplatin sensitivity via PDE4B in p53-mutant colorectal cancer. [PDF]
Wei PL +5 more
europepmc +1 more source
LSD1-GLS2 axis drives subtype-specific chemoresistance in pancreatic cancer through glutaminolysis reprogramming. [PDF]
Wang Z +14 more
europepmc +1 more source

